Search research articles
Contact Us
Filters
Showing results (81-90 of 102) with videos related to
Page
of 11
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
November 23, 2013
A study of prospective surveillance for inhibitors among persons with haemophilia in the United States
J M Soucie, C H Miller, F M Kelly, et al.
Annals of Surgery
|
June 1, 1996
Long-term results of breast conservation therapy for breast cancer
P T Neff, H D Bear, C V Pierce, et al.
Transplantation
|
January 20, 2006
Use of short tandem repeats for DNA fingerprinting to rapidly diagnose graft-versus-host disease in solid organ transplant patients
Jason J Schrager, Cindy L Vnencak-Jones, Stanley E Graber, et al.
Journal of Neurobiology
|
June 13, 1998
CEP-1347/KT7515 prevents motor neuronal programmed cell death and injury-induced dedifferentiation in vivo
M A Glicksman, A Y Chiu, C A Dionne, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 5, 2016
Von Willebrand factor for menorrhagia: a survey and literature review
M V Ragni, N Machin, L M Malec, et al.
International Journal of Cancer
|
August 7, 1997
CEP-751 inhibits TRK receptor tyrosine kinase activity in vitro exhibits anti-tumor activity
A M Camoratto, J P Jani, T S Angeles, et al.
Journal of Neurochemistry
|
October 28, 1999
CEP-1347 (KT7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insults
A C Maroney, J P Finn, D Bozyczko-Coyne, et al.
Transplantation
|
November 27, 2008
Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation
Robert T Neff, Frank P Hurst, Edward M Falta, et al.
American Journal of Nephrology
|
October 14, 2008
Influence of race on kidney transplantation in the Department of Defense healthcare system
James D Oliver, Robert T Neff, David B Leeser, et al.
Thrombosis Research
|
June 4, 2017
Feasibility of the Von Willebrand disease PREVENT trial
Margaret V Ragni, Nicoletta Machin, Andra H James, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 102) with videos related to
Sort By:
Page
of 11
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
November 23, 2013
A study of prospective surveillance for inhibitors among persons with haemophilia in the United States
J M Soucie, C H Miller, F M Kelly, et al.
Annals of Surgery
|
June 1, 1996
Long-term results of breast conservation therapy for breast cancer
P T Neff, H D Bear, C V Pierce, et al.
Transplantation
|
January 20, 2006
Use of short tandem repeats for DNA fingerprinting to rapidly diagnose graft-versus-host disease in solid organ transplant patients
Jason J Schrager, Cindy L Vnencak-Jones, Stanley E Graber, et al.
Journal of Neurobiology
|
June 13, 1998
CEP-1347/KT7515 prevents motor neuronal programmed cell death and injury-induced dedifferentiation in vivo
M A Glicksman, A Y Chiu, C A Dionne, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 5, 2016
Von Willebrand factor for menorrhagia: a survey and literature review
M V Ragni, N Machin, L M Malec, et al.
International Journal of Cancer
|
August 7, 1997
CEP-751 inhibits TRK receptor tyrosine kinase activity in vitro exhibits anti-tumor activity
A M Camoratto, J P Jani, T S Angeles, et al.
Journal of Neurochemistry
|
October 28, 1999
CEP-1347 (KT7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insults
A C Maroney, J P Finn, D Bozyczko-Coyne, et al.
Transplantation
|
November 27, 2008
Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation
Robert T Neff, Frank P Hurst, Edward M Falta, et al.
American Journal of Nephrology
|
October 14, 2008
Influence of race on kidney transplantation in the Department of Defense healthcare system
James D Oliver, Robert T Neff, David B Leeser, et al.
Thrombosis Research
|
June 4, 2017
Feasibility of the Von Willebrand disease PREVENT trial
Margaret V Ragni, Nicoletta Machin, Andra H James, et al.
Page
of 11